GDF5 therapeutic potential for Duchenne Muscular Dystrophy gene therapy optimization
Domains
Life Sciences [q-bio]| Origin | Files produced by the author(s) |
|---|
Conference Papers
Year : 2022
France Piétri-Rouxel : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-04000417
Submitted on : Monday, February 27, 2023-2:39:06 PM
Last modification on : Thursday, August 22, 2024-3:14:22 AM
Dates and versions
Identifiers
- HAL Id : hal-04000417 , version 1
Cite
France Piétri‐rouxel. GDF5 therapeutic potential for Duchenne Muscular Dystrophy gene therapy optimization. 12th Japanese-French Workshop “New insights in personalized medicine for neuromuscular diseases: From Basic to Applied Myology”, Gisèle Bonne, Sep 2022, Giverny, France. ⟨hal-04000417⟩
Collections
12
View
31
Download